| Hazard ratio (95% CI) |
---|
 | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 |
---|
Outcome
|
N
= 1,090
|
N
= 1,080
|
N
= 1,092
|
N
= 1,090
|
All-cause death | 1.00 | 0.96 (0.72, 1.29) | 1.15 (0.87, 1.54) | 1.88a (1.45, 2.46) |
CHD mortality | 1.00 | 0.97 (0.71, 1.33) | 1.17 (0.86, 1.60) | 1.99a (1.49, 2.66) |
Coronary incidence | 1.00 | 0.91 (0.72, 1.15) | 0.96 (0.76, 1.21) | 1.36b (1.08, 1.69) |
Stroke | 1.00 | 0.65 (0.32, 1.34) | 0.59 (0.27, 1.29) | 1.31 (0.69, 2.49) |
- aP < 0.001 in comparison to the first quartile; bP < 0.01. in comparison to first quartile; cTrend test performed using serum urate as a continuous variable. The covariates adjusted for in this regression included: age, gender, African-American ethnicity, body mass index, blood pressure/hypertension, smoking, diabetes status, physical activity measure, hyperlipidemia, hypertriglyceridemia, renal function, and other non-steroidal anti-inflammatory drug use.
- CHD, coronary heart disease; CI, confidence interval; N, number.